These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression. Martín-Henao GA; Quiroga R; Sureda A; González JR; Moreno V; García J Haematologica; 2000 Feb; 85(2):139-46. PubMed ID: 10681720 [TBL] [Abstract][Full Text] [Related]
3. Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia. Kawaishi K; Kimura A; Katoh O; Sasaki A; Oguma N; Ihara A; Satow Y Br J Haematol; 1996 May; 93(2):367-74. PubMed ID: 8639430 [TBL] [Abstract][Full Text] [Related]
4. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors? Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609 [TBL] [Abstract][Full Text] [Related]
5. [Expression of beta 2 integrins and L-selectin on CML cells after treatment with IFN-alpha and allo-bone marrow transplantation]. Tong X; Luo S; Hong W Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):474-6. PubMed ID: 11235567 [TBL] [Abstract][Full Text] [Related]
6. Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice. Pelletier SD; Hong DS; Hu Y; Liu Y; Li S Blood; 2004 Oct; 104(7):2163-71. PubMed ID: 15213099 [TBL] [Abstract][Full Text] [Related]
7. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL. Aljedai A; Buckle AM; Hiwarkar P; Syed F PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484 [TBL] [Abstract][Full Text] [Related]
8. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012 [TBL] [Abstract][Full Text] [Related]
9. CD7 expression by CD34+ cells in CML patients, of prognostic significance? Normann AP; Egeland T; Madshus IH; Heim S; Tjønnfjord GE Eur J Haematol; 2003 Oct; 71(4):266-75. PubMed ID: 12950236 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. Verfaillie CM; McCarthy JB; McGlave PB J Clin Invest; 1992 Oct; 90(4):1232-41. PubMed ID: 1383271 [TBL] [Abstract][Full Text] [Related]
11. BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cells. Jongen-Lavrencic M; Salesse S; Delwel R; Verfaillie CM Leukemia; 2005 Mar; 19(3):373-80. PubMed ID: 15674360 [TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function. Bhatia R; Wayner EA; McGlave PB; Verfaillie CM J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835 [TBL] [Abstract][Full Text] [Related]
13. BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients. Levescot A; Flamant S; Basbous S; Jacomet F; Féraud O; Anne Bourgeois E; Bonnet ML; Giraud C; Roy L; Barra A; Chomel JC; Turhan A; Guilhot F; Girard JP; Gombert JM; Herbelin A Cancer Res; 2014 May; 74(10):2669-76. PubMed ID: 24675360 [TBL] [Abstract][Full Text] [Related]
14. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors. Chu S; McDonald T; Bhatia R Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561 [TBL] [Abstract][Full Text] [Related]
15. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function. Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074 [TBL] [Abstract][Full Text] [Related]
16. [A preliminary study on mechanisms for resistance of CML patient BM-derived bcr/abl+ and Flk1+CD31-CD34- stem cells to STI571 in vitro]. Song YP; Fang BJ; Wei XD; Zheng S Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1004-9. PubMed ID: 16403268 [TBL] [Abstract][Full Text] [Related]
17. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia. Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222 [TBL] [Abstract][Full Text] [Related]
19. Functional ramifications for the loss of P-selectin expression on hematopoietic and leukemic stem cells. Sullivan C; Chen Y; Shan Y; Hu Y; Peng C; Zhang H; Kong L; Li S PLoS One; 2011; 6(10):e26246. PubMed ID: 22039451 [TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma. Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]